What's Happening?
Filmmaking duo Dan Berk and Robert Olsen have sold an untitled pitch for a contained action thriller to Lionsgate. The pair, known for their work on the high-concept action comedy 'Novocaine,' which starred Jack Quaid and opened at number one at the box
office last year, will write and direct the new project. Specific plot details for the upcoming film are currently being kept under wraps. Chris Bremner and Jeff Arkuss will produce the film through their banner, Unknown Quantity, with Chelsea Kujawa overseeing the project for Lionsgate. Robert Melnik handled the negotiation of the deals on behalf of the studio. Berk and Olsen's previous works also include the Paramount+ genre-bender 'Significant Other' and the SXSW horror comedy 'Villains.' They are also slated to direct the Ludacris action film 'Limited Edition' for Universal/87North.
Why It's Important?
This deal signifies a continued investment by Lionsgate in established and successful filmmaking talent, particularly those with a track record of box office performance and critical acclaim in the action and comedy genres. The involvement of Chris Bremner, a multi-hyphenate who recently signed a writing and producing deal with Sony after co-writing blockbusters like 'Bad Boys for Life' and 'Bad Boys: Ride or Die,' further underscores the potential commercial appeal of this project. For Berk and Olsen, securing another major studio deal, especially after the success of 'Novocaine,' solidifies their position in Hollywood as bankable writer-directors. This move could lead to more high-profile projects for the duo and potentially influence future studio decisions regarding similar action-comedy or contained thriller concepts. The collaboration between these established names suggests a strategic effort to produce commercially viable and entertaining content for a broad audience.
What's Next?
Dan Berk and Robert Olsen will proceed with writing the script for the untitled action thriller, followed by directing the film for Lionsgate. While specific plot details remain undisclosed, the project is expected to move into pre-production once the script is finalized. Chris Bremner and Jeff Arkuss will continue their roles as producers through Unknown Quantity, working alongside Chelsea Kujawa from Lionsgate. The success of 'Novocaine' and the involvement of experienced producers suggest that Lionsgate will likely prioritize this project for development. Further announcements regarding casting and a production timeline are anticipated as the project progresses. This new venture will also be watched closely by industry observers, especially given Berk and Olsen's upcoming direction of 'Limited Edition' for Universal/87North.
Beyond the Headlines
The trend of writer-directors selling high-concept pitches to major studios highlights a shift in Hollywood towards empowering creators who can deliver a complete vision from script to screen. This approach can streamline the production process and maintain a consistent artistic voice, potentially leading to more cohesive and successful films. The 'contained action thriller' genre, in particular, often appeals to studios due to its potential for cost-effectiveness while still delivering high-stakes entertainment. The success of films like 'Novocaine,' which blend action with comedic elements, suggests a growing audience appetite for genre-bending narratives. This could encourage more filmmakers to explore innovative combinations of genres, pushing creative boundaries within the studio system and offering fresh perspectives on traditional action tropes.













